Shares of Cronos Group Inc. (NASDAQ:CRON – Get Free Report) were up 8.8% during mid-day trading on Wednesday . The company traded as high as $2.03 and last traded at $2.05. 775,386 shares changed hands during mid-day trading, a decline of 42% from the average daily volume of 1,347,799 shares. The stock had previously closed at $1.88.
Cronos Group Stock Down 2.2 %
The company’s fifty day simple moving average is $1.98 and its 200 day simple moving average is $2.13. The firm has a market capitalization of $755.04 million, a PE ratio of -15.35, a price-to-earnings-growth ratio of 1.71 and a beta of 0.97.
Hedge Funds Weigh In On Cronos Group
A number of institutional investors have recently added to or reduced their stakes in the company. Jones Financial Companies Lllp grew its position in shares of Cronos Group by 64.5% in the 4th quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company’s stock worth $34,000 after buying an additional 6,520 shares during the period. Thompson Davis & CO. Inc. purchased a new stake in Cronos Group in the fourth quarter worth about $29,000. SBI Securities Co. Ltd. bought a new position in shares of Cronos Group during the fourth quarter valued at approximately $30,000. Quantbot Technologies LP purchased a new position in shares of Cronos Group during the third quarter valued at approximately $37,000. Finally, International Assets Investment Management LLC boosted its position in shares of Cronos Group by 119.0% in the 3rd quarter. International Assets Investment Management LLC now owns 41,643 shares of the company’s stock worth $91,000 after purchasing an additional 22,628 shares in the last quarter. Institutional investors own 8.71% of the company’s stock.
About Cronos Group
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Recommended Stories
- Five stocks we like better than Cronos Group
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Broadcom’s Bull Run: Time to Jump In?
- The Most Important Warren Buffett Stock for Investors: His Own
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.
